1. Home
  2. BCYC vs FPH Comparison

BCYC vs FPH Comparison

Compare BCYC & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • FPH
  • Stock Information
  • Founded
  • BCYC 2009
  • FPH 2009
  • Country
  • BCYC United Kingdom
  • FPH United States
  • Employees
  • BCYC N/A
  • FPH N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • FPH Real Estate
  • Sector
  • BCYC Health Care
  • FPH Finance
  • Exchange
  • BCYC Nasdaq
  • FPH Nasdaq
  • Market Cap
  • BCYC 449.5M
  • FPH 390.0M
  • IPO Year
  • BCYC 2019
  • FPH 2017
  • Fundamental
  • Price
  • BCYC $6.30
  • FPH $6.16
  • Analyst Decision
  • BCYC Buy
  • FPH
  • Analyst Count
  • BCYC 11
  • FPH 0
  • Target Price
  • BCYC $20.73
  • FPH N/A
  • AVG Volume (30 Days)
  • BCYC 345.2K
  • FPH 171.5K
  • Earning Date
  • BCYC 10-30-2025
  • FPH 10-29-2025
  • Dividend Yield
  • BCYC N/A
  • FPH N/A
  • EPS Growth
  • BCYC N/A
  • FPH 83.55
  • EPS
  • BCYC N/A
  • FPH 1.29
  • Revenue
  • BCYC $28,339,000.00
  • FPH $193,904,000.00
  • Revenue This Year
  • BCYC N/A
  • FPH N/A
  • Revenue Next Year
  • BCYC N/A
  • FPH N/A
  • P/E Ratio
  • BCYC N/A
  • FPH $4.88
  • Revenue Growth
  • BCYC N/A
  • FPH N/A
  • 52 Week Low
  • BCYC $6.10
  • FPH $3.42
  • 52 Week High
  • BCYC $21.60
  • FPH $6.71
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 36.23
  • FPH 55.33
  • Support Level
  • BCYC $6.17
  • FPH $6.18
  • Resistance Level
  • BCYC $6.89
  • FPH $6.47
  • Average True Range (ATR)
  • BCYC 0.46
  • FPH 0.19
  • MACD
  • BCYC -0.07
  • FPH 0.03
  • Stochastic Oscillator
  • BCYC 7.91
  • FPH 63.41

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

Share on Social Networks: